The vascular endothelium comprises a dynamic interface with the blood and acts as an integrator and transducer of both biochemical (e.g. inflammatory cytokines) and biomechanical (e.g. laminar shear stress) stimuli. Stimulation of the endothelium with pro-inflammatory cytokines renders the endothelium dysfunctional and induces a proadhesive and pro-thrombotic phenotype. In contrast, exposure to laminar flow induces critical gene products that confer potent anti-thrombotic, anti-adhesive, and anti-inflammatory properties. The balance of these biochemical and biomechanical stimuli critically regulates vascular function under physiologic and pathologic condition. KLF4 is a member of the Kruppel-like family of zinc-finger transcription factors that regulate critical processes such as cellular differentiation and function. Studies in our laboratory demonstrate that KLF4 is expressed in arterial and venous endothelial cells (ECs) in vitro and in vivo. Exposure of endothelial cells to pro-inflammatory stimuli or laminar shear stress induces KLF4 expression. In vitro gain and loss-of-function studies reveal that (1) KLF4 inhibits the cytokine-induced expression of pro-adhesive, prothrombotic factors such VCAM-1 and tissue factor (TF) and (2) KLF4 induces the expression of flow-regulated factors such as endothelial nitric oxide synthase (eNOS) and thrombomodulin (TM). Consistent with these differential effects on target genes, sustained expression of KLF4 inhibits immune cell adhesion to an endothelial monolayer and prolongs blood-clotting time. Based on these observations, we hypothesize that KLF4 may serve as a critical transcriptional regulator of endothelial cell function and vascular homeostasis. The studies outlined in this proposal will explore (1) the molecular basis and functional consequences of altering KLF4 expression on cytokine-mediated EC activation in vitro, (2) the molecular basis for flow-mediated induction of KLF4 and the functional consequences of altering KLF4 levels on endothelial gene expression in vitro, and (3) the effect of KLF4 over expression and deficiency on endothelial gene expression and vessel function in vivo. The results of the studies outlined in this proposal will provide insights regarding KLF4 function in EC biology under physiologic and pathologic states. In addition, they may provide the foundation for novel therapies directed at a broad spectrum of vascular inflammatory disease states such atherosclerosis.

Public Health Relevance

The vascular endothelium comprises a dynamic interface with the blood and acts as an integrator and transducer of both biochemical (e.g. inflammatory cytokines) and biomechanical (e.g. laminar shear stress) stimuli. The molecular mechanisms regulating the effect of these diverse stimuli on vessel biology remain poorly understood. This application explores the role of a factor termed KLF4 in endothelial homeostasis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL097593-02
Application #
8069849
Study Section
Special Emphasis Panel (ZRG1-VH-G (02))
Program Officer
Srinivas, Pothur R
Project Start
2010-05-07
Project End
2014-04-30
Budget Start
2011-05-01
Budget End
2012-04-30
Support Year
2
Fiscal Year
2011
Total Cost
$392,500
Indirect Cost
Name
Case Western Reserve University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Sun, Haipeng; Olson, Kristine C; Gao, Chen et al. (2016) Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure. Circulation 133:2038-49
Xiong, Ye; Lingrel, Jerry B; Wüthrich, Marcel et al. (2016) Transcription Factor KLF2 in Dendritic Cells Downregulates Th2 Programming via the HIF-1?/Jagged2/Notch Axis. MBio 7:
Prosdocimo, Domenick A; Sabeh, M Khaled; Jain, Mukesh K (2015) Kruppel-like factors in muscle health and disease. Trends Cardiovasc Med 25:278-87
Jain, Mukesh K; Sangwung, Panjamaporn; Hamik, Anne (2014) Regulation of an inflammatory disease: Krüppel-like factors and atherosclerosis. Arterioscler Thromb Vasc Biol 34:499-508
Tugal, Derin; Jain, Mukesh K; Simon, Daniel I (2014) Endothelial KLF4: crippling vascular injury? J Am Heart Assoc 3:e000769
Shi, Hong; Sheng, Baiyang; Zhang, Chao et al. (2014) Myeloid Kruppel-like factor 2 deficiency exacerbates neurological dysfunction and neuroinflammation in a murine model of multiple sclerosis. J Neuroimmunol 274:234-9
Nayak, Lalitha; Shi, Hong; Atkins, G Brandon et al. (2014) The thromboprotective effect of bortezomib is dependent on the transcription factor Kruppel-like factor 2 (KLF2). Blood 123:3828-31
Shatat, Mohammad A; Tian, Hongmei; Zhang, Rongli et al. (2014) Endothelial Krüppel-like factor 4 modulates pulmonary arterial hypertension. Am J Respir Cell Mol Biol 50:647-53
Adams, Gregory N; Stavrou, Evi X; Fang, Chao et al. (2013) Prolylcarboxypeptidase promotes angiogenesis and vascular repair. Blood 122:1522-31
Mudd, Joseph C; Murphy, Patrick; Manion, Maura et al. (2013) Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodes. Blood 121:2914-22

Showing the most recent 10 out of 38 publications